National Center for Human Factors in Healthcare
Washington D.C., District of Columbia, 20008, United States
NCT Number: NCT03488849
SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway.
Cricothyroid membrane identification accuracy has been reported to be 30-62% in the literature [Bai15, Ell10, Kri15, Lam15]. The current study assesses SureCRIC-assisted medic performance in identifying the cricothyroid membrane in a diverse standardized patient population.
Looking for future studies?
Notify MeAll sexes
Interventional
Washington D.C., District of Columbia, 20008, United States
The study is a two-arm, open-label study involving users - largely licensed paramedics or combat medics - identifying the cricothyroid membranes on healthy volunteers. The Control Group will perform cricothyroid membrane identification on healthy male and female volunteers of varying heights, weights, and BMI's with the standard, freehand approach. The Experimental Group will perform cricothyroid membrane identification on the volunteers with the help of the SureCRIC. An expert verifier (senior otolaryngologist) will verify correct cricothyroid membrane identification and will not be blinded in order to reduce any error that may be introduced by SureCRIC removal and subsequent skin movement. The primary endpoint is a pass/fail assessment for cricothyroid membrane identification. The main secondary endpoint is time to cricothyroid membrane identification. The study design was recommended by FDA. The study, per FDA guidance, is not designed for statistical comparisons and only descriptive statistics are provided.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Participants (Users):
Inclusion criteria
Exclusion criteria
Healthy Volunteers (Standardized Patients):
Inclusion criteria
Exclusion criteria
SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway.
Freehand palpation approach to identification of the cricothyroid membrane
Time frame: 1 day
pass/fail assessment for CTM identification as gauged by expert (senior orolaryngologist)
Time frame: 1 day
time to cricothyroid membrane identification as measured by direct observation
InnoVital Systems, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06227234
Airway Obstruction, Choking
Calgary, Alberta, Canada
View Trial DetailsNCT06742476
Airway Obstruction, Respiration Disorders
Al Fayyum, Egypt
View Trial DetailsNCT06609499
Airway Obstruction, Respiration Disorders
Radom, Masovian Voivodeship, Poland
View Trial DetailsNCT05748626
Airway Obstruction, Pathological Conditions, Signs and Symptoms
Chicago, Illinois, United States
View Trial Details